WindRose Health Investors has announced the acquisition of CardioOne.
CardioOne, founded in 2022 and based in Houston, is a physician enablement company that serves independent cardiologists. The company offers what is described as an integrated technology platform, a practice optimization program, a workforce solution and a growth engine.
WindRose, founded in 2000 and based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.
Terms of the acquisition were not disclosed.
